ICG Group (Nasdaq: ICGE ) is expected to report Q4 earnings on Feb. 21. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ICG Group's revenues will increase 45.8% and EPS will shrink to a loss.
The average estimate for revenue is $52.6 million. On the bottom line, the average EPS estimate is -$0.20.
Last quarter, ICG Group tallied revenue of $51.2 million. GAAP reported sales were 46% higher than the prior-year quarter's $35.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.59. GAAP EPS were $0.59 for Q3 versus -$0.08 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 39.6%, 30 basis points worse than the prior-year quarter. Operating margin was -16.4%, 1,700 basis points worse than the prior-year quarter. Net margin was 41.6%, 5,000 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $185.6 million. The average EPS estimate is $0.03.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 56 members out of 68 rating the stock outperform, and 12 members rating it underperform. Among 20 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 16 give ICG Group a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ICG Group is buy, with an average price target of $13.00.
Looking for alternatives to ICG Group? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add ICG Group to My Watchlist.